DEXAMETHASONE 1.5 MG

DEXAMETHASONE 1.5 MG was reported 161149 times

DEXAMETHASONE 1.5 MG is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN BOCAVIRUS INFECTION 78 0.6667
1 PLASMA CELL LEUKAEMIA 211 0.5275
2 PLASMA CELL MYELOMA RECURRENT 627 0.4166
3 MONOCLONAL IMMUNOGLOBULIN PRESENT 186 0.3591
4 PLASMACYTOMA 474 0.3577
5 LIGHT CHAIN ANALYSIS INCREASED 193 0.3374
6 PLASMA CELL MYELOMA 7054 0.3168
7 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 79 0.3110
8 MYCOBACTERIUM CHELONAE INFECTION 114 0.2597
9 CARDIAC AMYLOIDOSIS 104 0.2494
10 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 187 0.2401
11 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 286 0.2250
12 HYPOFIBRINOGENAEMIA 125 0.2185
13 SECONDARY IMMUNODEFICIENCY 126 0.2180
14 PARAINFLUENZAE VIRUS INFECTION 184 0.2145
15 FEBRILE BONE MARROW APLASIA 551 0.2046
16 CYTOMEGALOVIRUS CHORIORETINITIS 235 0.2040
17 PSEUDOMONAL SEPSIS 192 0.1655
18 PNEUMONIA INFLUENZAL 105 0.1633
19 AMYLOIDOSIS 182 0.1568
20 NEUTROPENIC SEPSIS 773 0.1557
21 PERIPHERAL MOTOR NEUROPATHY 143 0.1544
22 STRONGYLOIDIASIS 152 0.1512
23 NEUTROPENIC INFECTION 105 0.1477
24 MULTIPLE MYELOMA 672 0.1441
25 OSTEOLYSIS 191 0.1382
26 AUTONOMIC NEUROPATHY 85 0.1367
27 FEBRILE INFECTION 89 0.1344
28 TUMOUR LYSIS SYNDROME 643 0.1317
29 CYTOPENIA 566 0.1307
30 PERIPHERAL SENSORY NEUROPATHY 459 0.1261
31 BONE LESION 290 0.1227
32 VENOOCCLUSIVE LIVER DISEASE 366 0.1216
33 ENTEROBACTER INFECTION 119 0.1149
34 ESCHERICHIA BACTERAEMIA 140 0.1143
35 PERIPHERAL SENSORIMOTOR NEUROPATHY 79 0.1137
36 RHINOVIRUS INFECTION 168 0.1126
37 FULL BLOOD COUNT INCREASED 78 0.1114
38 FEBRILE NEUTROPENIA 4252 0.1108
39 ACUTE LYMPHOCYTIC LEUKAEMIA 208 0.1092
40 HAEMATOTOXICITY 518 0.1076
41 MYELOPATHY 123 0.1049
42 SOFT TISSUE DISORDER 90 0.1029
43 ADENOCARCINOMA OF COLON 118 0.0997
44 NEUTROPENIC COLITIS 99 0.0995
45 HUMAN HERPESVIRUS 6 INFECTION 130 0.0946
46 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 101 0.0938
47 PNEUMATOSIS INTESTINALIS 146 0.0928
48 PNEUMOCYSTIS JIROVECII PNEUMONIA 474 0.0912
49 ASPERGILLUS INFECTION 281 0.0907
50 MUCORMYCOSIS 130 0.0907
51 SQUAMOUS CELL CARCINOMA OF SKIN 321 0.0901
52 FULL BLOOD COUNT DECREASED 989 0.0894
53 NEUROPATHY PERIPHERAL 4850 0.0892
54 COVID-19 PNEUMONIA 105 0.0885
55 PNEUMONIA PNEUMOCOCCAL 83 0.0868
56 HEPATITIS B REACTIVATION 140 0.0863
57 THERAPY PARTIAL RESPONDER 222 0.0857
58 LEUKAEMIA RECURRENT 107 0.0857
59 PNEUMONIA FUNGAL 139 0.0853
60 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 476 0.0853
61 APLASIA 135 0.0847
62 ESCHERICHIA SEPSIS 170 0.0845
63 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 149 0.0838
64 OSTEOSCLEROSIS 95 0.0837
65 PATHOLOGICAL FRACTURE 290 0.0835
66 SYSTEMIC CANDIDA 109 0.0828
67 BRONCHOPULMONARY ASPERGILLOSIS 361 0.0824
68 PRIMARY SEQUESTRUM 74 0.0816
69 JC VIRUS INFECTION 72 0.0814
70 NEUTROPENIA 5967 0.0813
71 CYTOMEGALOVIRUS VIRAEMIA 167 0.0812
72 PNEUMONIA VIRAL 147 0.0794
73 THROMBOCYTOPENIA 5631 0.0793
74 BONE MARROW TOXICITY 96 0.0785
75 MUCOSAL INFLAMMATION 1328 0.0784
76 CAPILLARY LEAK SYNDROME 94 0.0771
77 PROTEIN TOTAL INCREASED 124 0.0759
78 HISTIOCYTOSIS HAEMATOPHAGIC 230 0.0757
79 DIVERTICULAR PERFORATION 121 0.0754
80 PNEUMONIA CYTOMEGALOVIRAL 87 0.0742
81 PANCYTOPENIA 2633 0.0731
82 CUSHINGOID 148 0.0731
83 MYELODYSPLASTIC SYNDROME 738 0.0725
84 JUGULAR VEIN THROMBOSIS 86 0.0720
85 DIFFUSE LARGE B-CELL LYMPHOMA 255 0.0712
86 STEM CELL TRANSPLANT 121 0.0707
87 POLYNEUROPATHY 478 0.0706
88 BLOOD CULTURE POSITIVE 181 0.0703
89 BACTERIAL SEPSIS 152 0.0697
90 CYTOKINE RELEASE SYNDROME 251 0.0691
91 METASTASES TO MENINGES 79 0.0678
92 BACTERAEMIA 461 0.0674
93 CLOSTRIDIUM DIFFICILE COLITIS 474 0.0673
94 HYPOGAMMAGLOBULINAEMIA 193 0.0669
95 SPINAL CORD COMPRESSION 176 0.0660
96 GASTROINTESTINAL TOXICITY 157 0.0654
97 SEPTIC SHOCK 1766 0.0653
98 NEUTROPHIL COUNT DECREASED 1448 0.0649
99 NOCARDIOSIS 93 0.0646
100 COMPRESSION FRACTURE 197 0.0646
101 HYPERCALCAEMIA 518 0.0645
102 STAPHYLOCOCCAL BACTERAEMIA 159 0.0628
103 LYMPHOPENIA 524 0.0627
104 BONE MARROW FAILURE 1111 0.0626
105 HYPERTRIGLYCERIDAEMIA 230 0.0617
106 SOFT TISSUE INFECTION 71 0.0615
107 MYELOSUPPRESSION 104 0.0612
108 STAPHYLOCOCCAL SEPSIS 224 0.0605
109 ENTEROCOCCAL INFECTION 180 0.0604
110 HICCUPS 318 0.0602
111 NEUROTOXICITY 564 0.0597
112 CARDIOTOXICITY 260 0.0587
113 EMBOLISM VENOUS 113 0.0578
114 BRAIN ABSCESS 86 0.0578
115 EMBOLISM 344 0.0577
116 LEUKOPENIA 1888 0.0574
117 PERIODONTITIS 90 0.0573
118 VENOUS THROMBOSIS 164 0.0569
119 EXPOSED BONE IN JAW 112 0.0565
120 NEUTROPHIL COUNT ABNORMAL 92 0.0565
121 HYPOPHOSPHATAEMIA 244 0.0561
122 OESOPHAGEAL CANDIDIASIS 140 0.0549
123 PSEUDOMONAS INFECTION 274 0.0543
124 PARAPLEGIA 111 0.0539
125 MULTIPLE ORGAN DYSFUNCTION SYNDROME 704 0.0538
126 METASTASES TO SPINE 105 0.0535
127 PSYCHOLOGICAL TRAUMA 423 0.0535
128 HYPERBILIRUBINAEMIA 352 0.0525
129 NEOPLASM RECURRENCE 115 0.0523
130 ENTERITIS 189 0.0518
131 ATELECTASIS 373 0.0518
132 ENTEROCOLITIS 160 0.0517
133 VENOOCCLUSIVE DISEASE 83 0.0516
134 ILEUS PARALYTIC 157 0.0515
135 METASTASES TO CENTRAL NERVOUS SYSTEM 377 0.0515
136 ACUTE MYELOID LEUKAEMIA 517 0.0515
137 SECOND PRIMARY MALIGNANCY 271 0.0510
138 RESPIRATORY SYNCYTIAL VIRUS INFECTION 167 0.0507
139 CYTOMEGALOVIRUS INFECTION 536 0.0505
140 HYPOALBUMINAEMIA 243 0.0503
141 PLATELET COUNT DECREASED 3312 0.0503
142 SEPSIS 3767 0.0503
143 LUNG CONSOLIDATION 95 0.0499
144 LARGE INTESTINE PERFORATION 234 0.0498
145 LUNG INFILTRATION 361 0.0494
146 LOBAR PNEUMONIA 91 0.0491
147 KLEBSIELLA INFECTION 139 0.0486
148 SPINAL COMPRESSION FRACTURE 288 0.0477
149 ADRENAL INSUFFICIENCY 270 0.0475
150 LEUKOENCEPHALOPATHY 128 0.0471
151 PNEUMONITIS 715 0.0465
152 DEEP VEIN THROMBOSIS 2364 0.0459
153 PLEURITIC PAIN 97 0.0459
154 HYPOXIA 1001 0.0456
155 HYPOCALCAEMIA 561 0.0454
156 BRAIN HERNIATION 95 0.0453
157 TASTE DISORDER 207 0.0452
158 DISEASE PROGRESSION 2902 0.0448
159 CEREBELLAR SYNDROME 77 0.0448
160 NON-SMALL CELL LUNG CANCER 98 0.0447
161 LABORATORY TEST ABNORMAL 832 0.0446
162 HAIR DISORDER 329 0.0442
163 BRAIN OEDEMA 377 0.0436
164 HYPERGLYCAEMIA 1093 0.0434
165 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 122 0.0434
166 ATRIAL FLUTTER 251 0.0433
167 FAILURE TO THRIVE 171 0.0432
168 HAEMOGLOBIN ABNORMAL 160 0.0430
169 ATYPICAL PNEUMONIA 73 0.0427
170 ORAL CANDIDIASIS 345 0.0424
171 PERFORMANCE STATUS DECREASED 142 0.0424
172 HYPOKALAEMIA 1235 0.0414
173 BACTERIAL INFECTION 457 0.0410
174 WHITE BLOOD CELL COUNT DECREASED 2703 0.0410
175 LUNG ADENOCARCINOMA 79 0.0407
176 PNEUMONIA 8371 0.0406
177 ENCEPHALITIS 173 0.0404
178 CANDIDA INFECTION 368 0.0402
179 PNEUMONIA BACTERIAL 176 0.0402
180 MULTIPLE ALLERGIES 175 0.0401
181 SKIN TOXICITY 113 0.0399
182 LUNG INFECTION 629 0.0398
183 ANAEMIA 5154 0.0395
184 NECROTISING FASCIITIS 88 0.0394
185 PROTEIN TOTAL DECREASED 105 0.0392
186 INTESTINAL PERFORATION 294 0.0389
187 GASTROINTESTINAL PERFORATION 108 0.0388
188 POTENTIATING DRUG INTERACTION 83 0.0387
189 HEPATITIS B 173 0.0384
190 GUILLAIN-BARRE SYNDROME 112 0.0382
191 OSTEITIS 73 0.0382
192 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 218 0.0382
193 NON-CARDIAC CHEST PAIN 100 0.0381
194 ILEUS 314 0.0379
195 IMMUNOSUPPRESSION 174 0.0379
196 UROSEPSIS 224 0.0378
197 PULMONARY TOXICITY 132 0.0376
198 HEPATOSPLENOMEGALY 71 0.0373
199 BLOOD ALBUMIN DECREASED 215 0.0373
200 ACUTE PULMONARY OEDEMA 155 0.0372
201 BASAL CELL CARCINOMA 373 0.0371
202 RESPIRATORY TRACT INFECTION 583 0.0371
203 ACUTE RESPIRATORY DISTRESS SYNDROME 437 0.0371
204 APLASTIC ANAEMIA 124 0.0370
205 HAIR COLOUR CHANGES 360 0.0368
206 ELECTROLYTE IMBALANCE 262 0.0365
207 PULMONARY HAEMORRHAGE 213 0.0365
208 INFUSION RELATED REACTION 1183 0.0363
209 ESCHERICHIA INFECTION 179 0.0362
210 THROMBOTIC MICROANGIOPATHY 190 0.0361
211 SEASONAL ALLERGY 247 0.0360
212 PULMONARY EMBOLISM 2557 0.0359
213 OSTEONECROSIS OF JAW 709 0.0359
214 EPSTEIN-BARR VIRUS INFECTION 140 0.0355
215 PNEUMOCYSTIS JIROVECI PNEUMONIA 79 0.0353
216 ACUTE RESPIRATORY FAILURE 395 0.0353
217 PULMONARY THROMBOSIS 224 0.0352
218 INTRACARDIAC THROMBUS 89 0.0351
219 ESCHERICHIA URINARY TRACT INFECTION 102 0.0350
220 WHITE BLOOD CELL COUNT ABNORMAL 127 0.0350
221 CYSTITIS HAEMORRHAGIC 89 0.0345
222 RESPIRATORY FAILURE 1745 0.0342
223 OSTEONECROSIS 787 0.0342
224 MYOPATHY 202 0.0341
225 THROMBOSIS 1811 0.0340
226 STOMATITIS 1234 0.0338
227 LOOSE TOOTH 81 0.0334
228 MALIGNANT NEOPLASM PROGRESSION 1940 0.0333
229 HYPOMAGNESAEMIA 271 0.0333
230 LYMPHOCYTE COUNT DECREASED 371 0.0333
231 ORTHOSTATIC HYPOTENSION 381 0.0333
232 HAIR TEXTURE ABNORMAL 362 0.0332
233 NEPHROPATHY TOXIC 211 0.0331
234 PHLEBITIS 130 0.0330
235 RED BLOOD CELL COUNT DECREASED 584 0.0330
236 HUMERUS FRACTURE 111 0.0329
237 TACHYPNOEA 269 0.0329
238 HEPATOTOXICITY 428 0.0329
239 THROMBOPHLEBITIS 89 0.0329
240 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 82 0.0328
241 PLEURAL EFFUSION 1389 0.0328
242 HERPES SIMPLEX 143 0.0328
243 THROMBOPHLEBITIS SUPERFICIAL 96 0.0326
244 HYPOVOLAEMIA 135 0.0325
245 COLITIS 687 0.0325
246 LEFT VENTRICULAR DYSFUNCTION 144 0.0325
247 ENCEPHALOPATHY 507 0.0325
248 ORGANISING PNEUMONIA 87 0.0324
249 DISSEMINATED INTRAVASCULAR COAGULATION 344 0.0323
250 THROMBOTIC THROMBOCYTOPENIC PURPURA 91 0.0323
251 CARDIOPULMONARY FAILURE 98 0.0323
252 CEREBRAL ISCHAEMIA 132 0.0323
253 LOW BIRTH WEIGHT BABY 153 0.0322
254 RESPIRATORY DISTRESS 628 0.0319
255 ORAL DISORDER 159 0.0318
256 GINGIVITIS 119 0.0316
257 NEOPLASM PROGRESSION 616 0.0315
258 INFECTION 2676 0.0315
259 LYMPHOEDEMA 129 0.0315
260 ATRIAL FIBRILLATION 1980 0.0314
261 UNEVALUABLE EVENT 1670 0.0314
262 ENDOCARDITIS 105 0.0313
263 OESOPHAGITIS 236 0.0313
264 RED CELL DISTRIBUTION WIDTH INCREASED 71 0.0312
265 DEVICE RELATED INFECTION 357 0.0312
266 BODY HEIGHT DECREASED 268 0.0311
267 GRAFT VERSUS HOST DISEASE 161 0.0310
268 FOETAL GROWTH RESTRICTION 113 0.0310
269 EJECTION FRACTION DECREASED 294 0.0309
270 STRESS CARDIOMYOPATHY 97 0.0307
271 DEHYDRATION 2860 0.0306
272 MADAROSIS 298 0.0302
273 CLOSTRIDIUM DIFFICILE INFECTION 377 0.0300
274 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 201 0.0300
275 CONSTIPATION 3883 0.0300
276 ORAL PAIN 452 0.0299
277 CACHEXIA 106 0.0299
278 BONE DISORDER 416 0.0298
279 HAEMOGLOBIN DECREASED 2096 0.0296
280 PLATELET COUNT ABNORMAL 101 0.0296
281 STREPTOCOCCAL INFECTION 102 0.0296
282 LOWER RESPIRATORY TRACT INFECTION 759 0.0294
283 PULMONARY ALVEOLAR HAEMORRHAGE 96 0.0292
284 BLOOD POTASSIUM DECREASED 588 0.0291
285 IMPAIRED QUALITY OF LIFE 168 0.0291
286 DECUBITUS ULCER 169 0.0290
287 HYPONATRAEMIA 1122 0.0289
288 HYPERURICAEMIA 80 0.0288
289 ACUTE CORONARY SYNDROME 183 0.0288
290 MENINGITIS 130 0.0288
291 HAEMODYNAMIC INSTABILITY 127 0.0288
292 INTESTINAL ISCHAEMIA 108 0.0287
293 BLOOD MAGNESIUM DECREASED 149 0.0285
294 BLOOD LACTIC ACID INCREASED 89 0.0284
295 MENTAL STATUS CHANGES 566 0.0283
296 METASTASES TO BONE 256 0.0283
297 SPINAL OSTEOARTHRITIS 179 0.0283
298 RASH MACULO-PAPULAR 397 0.0282
299 METASTATIC NEOPLASM 77 0.0282
300 PYREXIA 6398 0.0281
301 HEPATOCELLULAR INJURY 329 0.0281
302 CELLULITIS 983 0.0281
303 TOOTH DISORDER 434 0.0280
304 ALANINE AMINOTRANSFERASE INCREASED 1235 0.0279
305 HEMIPARESIS 354 0.0278
306 MUSCULOSKELETAL CHEST PAIN 284 0.0278
307 BLOOD CALCIUM DECREASED 213 0.0276
308 DISEASE RECURRENCE 416 0.0275
309 MULTI-ORGAN FAILURE 473 0.0272
310 SINUS TACHYCARDIA 268 0.0272
311 BRONCHOSPASM 282 0.0271
312 BLOOD CREATINE INCREASED 77 0.0271
313 SMALL INTESTINAL OBSTRUCTION 219 0.0270
314 BLOOD LACTATE DEHYDROGENASE INCREASED 328 0.0269
315 GENERAL PHYSICAL HEALTH DETERIORATION 1726 0.0268
316 OSTEOMYELITIS 362 0.0268
317 WEIGHT FLUCTUATION 138 0.0268
318 PETECHIAE 192 0.0268
319 CHOLECYSTITIS ACUTE 109 0.0267
320 SUDDEN DEATH 223 0.0266
321 TROPONIN INCREASED 111 0.0265
322 BRONCHOPNEUMONIA 91 0.0265
323 COVID-19 324 0.0264
324 PARTIAL SEIZURES 86 0.0263
325 HYPERNATRAEMIA 85 0.0263
326 GENERALISED OEDEMA 213 0.0263
327 ODYNOPHAGIA 98 0.0261
328 CLOSTRIDIAL INFECTION 79 0.0261
329 HYDROCEPHALUS 98 0.0260
330 ACUTE KIDNEY INJURY 2274 0.0260
331 HERPES ZOSTER 967 0.0259
332 HAEMOLYTIC ANAEMIA 166 0.0257
333 PULSE ABSENT 92 0.0256
334 GASTROINTESTINAL INFLAMMATION 117 0.0256
335 HOSPICE CARE 109 0.0255
336 RIB FRACTURE 342 0.0255
337 PURULENT DISCHARGE 79 0.0254
338 HYPOPHAGIA 410 0.0254
339 LUMBAR VERTEBRAL FRACTURE 72 0.0254
340 IMMUNE THROMBOCYTOPENIC PURPURA 74 0.0253
341 HYPERAMMONAEMIA 80 0.0252
342 BLOOD CREATININE INCREASED 1141 0.0252
343 ASCITES 501 0.0252
344 ATAXIA 215 0.0251
345 NO THERAPEUTIC RESPONSE 307 0.0251
346 TRANSAMINASES INCREASED 377 0.0250
347 ENDOPHTHALMITIS 94 0.0250
348 LEUKOCYTOSIS 303 0.0249
349 CARDIAC FAILURE ACUTE 96 0.0249
350 LEFT VENTRICULAR HYPERTROPHY 76 0.0248
351 BLOOD BILIRUBIN INCREASED 492 0.0247
352 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 359 0.0247
353 SPINAL FRACTURE 301 0.0245
354 TOXICITY TO VARIOUS AGENTS 2517 0.0245
355 PROTHROMBIN TIME PROLONGED 126 0.0245
356 PROTEIN URINE PRESENT 75 0.0244
357 CANDIDIASIS 98 0.0244
358 DRUG RESISTANCE 361 0.0244
359 TOOTH EXTRACTION 212 0.0243
360 DERMATITIS ACNEIFORM 91 0.0242
361 OLIGURIA 107 0.0242
362 PAPILLOEDEMA 74 0.0241
363 ACUTE GRAFT VERSUS HOST DISEASE 76 0.0241
364 HAEMATOCRIT DECREASED 365 0.0241
365 BONE PAIN 960 0.0241
366 MALNUTRITION 169 0.0239
367 SKIN INFECTION 156 0.0239
368 ADVERSE DRUG REACTION 1080 0.0238
369 ERYSIPELAS 82 0.0238
370 BLOOD CALCIUM INCREASED 148 0.0237
371 SQUAMOUS CELL CARCINOMA 148 0.0237
372 UPPER RESPIRATORY TRACT INFECTION 716 0.0235
373 PERICARDITIS 138 0.0235
374 AGEUSIA 377 0.0235
375 RENAL IMPAIRMENT 1177 0.0234
376 PNEUMOTHORAX 234 0.0234
377 GENERAL PHYSICAL CONDITION ABNORMAL 93 0.0233
378 HAEMOLYSIS 128 0.0233
379 TOXIC EPIDERMAL NECROLYSIS 233 0.0233
380 PULMONARY OEDEMA 717 0.0233
381 HEPATOMEGALY 173 0.0233
382 JAW DISORDER 103 0.0232
383 HYDRONEPHROSIS 115 0.0232
384 OXYGEN SATURATION DECREASED 697 0.0232
385 THERAPY NON-RESPONDER 439 0.0231
386 NEOPLASM 155 0.0231
387 METASTASES TO LIVER 249 0.0230
388 DIARRHOEA 8985 0.0229
389 DECREASED APPETITE 3237 0.0229
390 MYOSITIS 124 0.0229
391 RENAL FAILURE 2266 0.0228
392 PULMONARY MASS 201 0.0227
393 GINGIVAL SWELLING 72 0.0226
394 PERICARDIAL EFFUSION 332 0.0226
395 SUPRAVENTRICULAR TACHYCARDIA 154 0.0226
396 NEURALGIA 332 0.0226
397 CARDIOMYOPATHY 239 0.0225
398 C-REACTIVE PROTEIN INCREASED 482 0.0225
399 COAGULOPATHY 272 0.0224
400 HYPOTENSION 2953 0.0224
401 DELIRIUM 487 0.0224
402 MOUTH ULCERATION 294 0.0224
403 ASPARTATE AMINOTRANSFERASE INCREASED 860 0.0223
404 VIRAL UPPER RESPIRATORY TRACT INFECTION 89 0.0223
405 INTRACRANIAL PRESSURE INCREASED 82 0.0223
406 PROTEINURIA 246 0.0222
407 BODY TEMPERATURE INCREASED 310 0.0221
408 FAECALOMA 76 0.0220
409 CATARACT 778 0.0220
410 MOUTH HAEMORRHAGE 106 0.0218
411 PURPURA 140 0.0217
412 GASTROENTERITIS 217 0.0216
413 NEUTROPHIL COUNT INCREASED 154 0.0216
414 BLOOD ALKALINE PHOSPHATASE INCREASED 417 0.0215
415 GASTROINTESTINAL INFECTION 118 0.0214
416 SERUM FERRITIN INCREASED 77 0.0214
417 CARDIAC FAILURE 1128 0.0214
418 COLITIS ISCHAEMIC 99 0.0214
419 NEUROLOGICAL SYMPTOM 79 0.0213
420 CHOLESTASIS 263 0.0213
421 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 85 0.0212
422 BRAIN NEOPLASM 118 0.0212
423 ACIDOSIS 114 0.0212
424 ORAL HERPES 237 0.0211
425 FEMORAL NECK FRACTURE 73 0.0211
426 STAPHYLOCOCCAL INFECTION 506 0.0211
427 RENAL FAILURE ACUTE 894 0.0210
428 CIRCULATORY COLLAPSE 271 0.0210
429 SINUS BRADYCARDIA 143 0.0210
430 RALES 81 0.0209
431 OEDEMA PERIPHERAL 1940 0.0207
432 ECCHYMOSIS 107 0.0206
433 URINE OUTPUT DECREASED 134 0.0206
434 BLOOD TEST ABNORMAL 155 0.0206
435 SKIN NECROSIS 77 0.0205
436 AGRANULOCYTOSIS 226 0.0204
437 ANAPHYLACTIC SHOCK 324 0.0203
438 SHOCK 303 0.0202
439 GINGIVAL PAIN 110 0.0202
440 SPINAL DISORDER 128 0.0202
441 DYSPNOEA EXERTIONAL 449 0.0202
442 APPENDICITIS 112 0.0201
443 DIVERTICULITIS 360 0.0201
444 VIRAL INFECTION 425 0.0201
445 GAMMA-GLUTAMYLTRANSFERASE INCREASED 343 0.0201
446 HYPERKALAEMIA 477 0.0201
447 HEPATIC FUNCTION ABNORMAL 452 0.0200
448 ACUTE HEPATIC FAILURE 167 0.0199
449 TACHYCARDIA 1169 0.0198
450 METABOLIC DISORDER 80 0.0198
451 SKIN MASS 77 0.0198
452 ASTHENIA 4862 0.0196
453 PAPULE 71 0.0196
454 LIVER FUNCTION TEST INCREASED 211 0.0196
455 WOUND INFECTION 113 0.0196
456 ACUTE MYOCARDIAL INFARCTION 441 0.0196
457 HEPATIC FAILURE 423 0.0194
458 METASTASES TO LUNG 134 0.0194
459 OEDEMA 695 0.0194
460 CHOLECYSTITIS 161 0.0194
461 FUNGAL INFECTION 413 0.0193
462 NECROSIS 78 0.0192
463 TOOTH ABSCESS 143 0.0191
464 STATUS EPILEPTICUS 144 0.0191
465 TRICUSPID VALVE INCOMPETENCE 105 0.0191
466 RENAL TUBULAR NECROSIS 124 0.0191
467 FLANK PAIN 119 0.0191
468 SKIN ULCER 329 0.0190
469 LIPASE INCREASED 103 0.0190
470 FATIGUE 9019 0.0189
471 PERIPHERAL SWELLING 1608 0.0189
472 ANAL INCONTINENCE 80 0.0189
473 EPISTAXIS 979 0.0188
474 BLOOD UREA INCREASED 251 0.0188
475 PRODUCT USE IN UNAPPROVED INDICATION 1893 0.0187
476 CYANOSIS 212 0.0187
477 URINARY TRACT INFECTION 1959 0.0186
478 SPINAL PAIN 129 0.0186
479 SUBDURAL HAEMATOMA 200 0.0186
480 BREAST CANCER METASTATIC 126 0.0186
481 MALIGNANT MELANOMA 167 0.0186
482 PREMATURE BABY 380 0.0185
483 RENAL CYST 104 0.0185
484 HAEMOPTYSIS 368 0.0185
485 VENTRICULAR EXTRASYSTOLES 141 0.0184
486 TENDERNESS 131 0.0184
487 BLOOD SODIUM DECREASED 229 0.0183
488 MYOCARDITIS 97 0.0183
489 TOOTH INFECTION 147 0.0183
490 FACIAL PARALYSIS 88 0.0182
491 ANAPHYLACTIC REACTION 589 0.0182
492 CONFUSIONAL STATE 2028 0.0181
493 BLOOD IRON DECREASED 114 0.0181
494 ANURIA 119 0.0180
495 INTERSTITIAL LUNG DISEASE 539 0.0180
496 PYELONEPHRITIS 100 0.0180
497 IMMUNE SYSTEM DISORDER 146 0.0180
498 PNEUMONIA ASPIRATION 291 0.0179
499 URINARY RETENTION 395 0.0179
500 SYNCOPE 1238 0.0178
501 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 88 0.0178
502 LYMPHADENOPATHY 411 0.0178
503 METABOLIC ACIDOSIS 343 0.0177
504 BLOOD COUNT ABNORMAL 241 0.0176
505 INCONTINENCE 128 0.0176
506 METASTASIS 76 0.0176
507 APHASIA 372 0.0176
508 ABSCESS 177 0.0175
509 UNRESPONSIVE TO STIMULI 308 0.0175
510 RENAL DISORDER 530 0.0175
511 BACK PAIN 2707 0.0175
512 BRONCHITIS 939 0.0174
513 DERMATITIS BULLOUS 85 0.0174
514 OSTEOPENIA 159 0.0174
515 FACE OEDEMA 212 0.0174
516 TOXIC SKIN ERUPTION 120 0.0174
517 MASS 167 0.0173
518 PANCREATITIS ACUTE 256 0.0173
519 SPLENOMEGALY 138 0.0173
520 BRADYCARDIA 636 0.0172
521 CARDIOMEGALY 171 0.0172
522 INCREASED TENDENCY TO BRUISE 114 0.0172
523 CARDIAC ARREST 1023 0.0171
524 VASCULITIS 126 0.0171
525 NAIL DISORDER 84 0.0171
526 SYNOVITIS 135 0.0171
527 PAIN IN JAW 350 0.0170
528 CHILLS 1299 0.0170
529 HEMIPLEGIA 103 0.0170
530 INFLUENZA 1158 0.0170
531 MITRAL VALVE INCOMPETENCE 139 0.0170
532 CARDIOGENIC SHOCK 139 0.0169
533 LETHARGY 689 0.0168
534 FLUID OVERLOAD 236 0.0168
535 TOOTHACHE 204 0.0168
536 POLYURIA 91 0.0167
537 HYPERTHERMIA 89 0.0166
538 SKIN LESION 282 0.0166
539 ISCHAEMIC STROKE 212 0.0166
540 VENTRICULAR FIBRILLATION 134 0.0166
541 GOUT 195 0.0166
542 DRUG INTOLERANCE 894 0.0166
543 CEREBRAL INFARCTION 290 0.0165
544 LIVER FUNCTION TEST ABNORMAL 398 0.0165
545 HAEMATURIA 415 0.0165
546 MYOCARDIAL ISCHAEMIA 155 0.0164
547 HEPATIC STEATOSIS 203 0.0164
548 SENSORY LOSS 91 0.0163
549 PULMONARY FIBROSIS 187 0.0163
550 LUNG DISORDER 499 0.0163
551 VITAMIN D DECREASED 95 0.0163
552 GASTROINTESTINAL DISORDER 743 0.0163
553 VOMITING 4988 0.0162
554 FAECAL INCONTINENCE 78 0.0162
555 PRODUCTIVE COUGH 439 0.0162
556 INCOHERENT 81 0.0161
557 INTERVERTEBRAL DISC DEGENERATION 111 0.0161
558 DYSPNOEA 5927 0.0160
559 GENERALISED TONIC-CLONIC SEIZURE 148 0.0159
560 IMPAIRED HEALING 324 0.0159
561 CARDIO-RESPIRATORY ARREST 505 0.0159
562 RASH PRURITIC 534 0.0159
563 HEPATITIS ACUTE 72 0.0159
564 RETINAL HAEMORRHAGE 80 0.0159
565 MUSCULAR WEAKNESS 1226 0.0158
566 ALOPECIA 2105 0.0158
567 DERMATITIS ALLERGIC 117 0.0158
568 RASH 4128 0.0158
569 HYPERAESTHESIA 95 0.0157
570 PROSTATE CANCER 265 0.0157
571 DYSGEUSIA 813 0.0157
572 GINGIVAL BLEEDING 136 0.0156
573 PERITONITIS 242 0.0156
574 BLOOD DISORDER 83 0.0156
575 CONJUNCTIVITIS 151 0.0155
576 URINARY INCONTINENCE 319 0.0155
577 IMMUNODEFICIENCY 110 0.0155
578 SINUS DISORDER 196 0.0155
579 HIP FRACTURE 321 0.0155
580 MUSCLE STRAIN 89 0.0155
581 WOUND 203 0.0155
582 COGNITIVE DISORDER 460 0.0155
583 MYOCLONUS 127 0.0154
584 STEVENS-JOHNSON SYNDROME 259 0.0154
585 DRUG TOXICITY 209 0.0153
586 EYE INFECTION 97 0.0153
587 PREMATURE DELIVERY 148 0.0153
588 TREATMENT FAILURE 695 0.0152
589 DENTAL CARIES 119 0.0152
590 INCREASED APPETITE 169 0.0152
591 HAEMORRHAGE INTRACRANIAL 178 0.0151
592 HAEMORRHOIDS 206 0.0151
593 DYSPHAGIA 932 0.0151
594 OFF LABEL USE 5707 0.0151
595 CYSTITIS 332 0.0150
596 HYPERLIPIDAEMIA 139 0.0150
597 VENTRICULAR TACHYCARDIA 170 0.0149
598 RESPIRATORY RATE INCREASED 87 0.0148
599 DIARRHOEA HAEMORRHAGIC 91 0.0148
600 DIZZINESS POSTURAL 79 0.0148
601 DEATH 7821 0.0148
602 HEPATIC ENCEPHALOPATHY 98 0.0147
603 LACRIMATION INCREASED 249 0.0147
604 RESPIRATORY DISORDER 292 0.0147
605 PATHOGEN RESISTANCE 72 0.0146
606 DYSPHONIA 543 0.0146
607 ALTERED STATE OF CONSCIOUSNESS 192 0.0146
608 DYSARTHRIA 390 0.0146
609 DIVERTICULUM 88 0.0145
610 LOCALISED INFECTION 223 0.0145
611 HYPERTENSIVE CRISIS 114 0.0145
612 ERYTHEMA MULTIFORME 95 0.0145
613 CEREBRAL HAEMORRHAGE 370 0.0145
614 PLATELET COUNT INCREASED 117 0.0144
615 INTRAOCULAR PRESSURE INCREASED 133 0.0144
616 RASH ERYTHEMATOUS 390 0.0144
617 RENAL FAILURE CHRONIC 111 0.0144
618 PERIPHERAL COLDNESS 134 0.0143
619 PELVIC FRACTURE 73 0.0143
620 DRUG ERUPTION 156 0.0143
621 BACK DISORDER 155 0.0143
622 MELAENA 226 0.0143
623 FLUID RETENTION 497 0.0142
624 SWELLING FACE 630 0.0142
625 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 202 0.0142
626 ABDOMINAL PAIN 2166 0.0142
627 PULMONARY CONGESTION 126 0.0142
628 NAUSEA 7264 0.0140
629 WEIGHT DECREASED 2503 0.0140
630 RASH GENERALISED 364 0.0140
631 NERVE INJURY 107 0.0140
632 SCIATICA 124 0.0140
633 PULMONARY HYPERTENSION 211 0.0139
634 MUSCLE ATROPHY 108 0.0138
635 DRUG-INDUCED LIVER INJURY 196 0.0138
636 INTERVERTEBRAL DISC PROTRUSION 216 0.0138
637 PARAESTHESIA ORAL 125 0.0137
638 BLOOD PRESSURE DECREASED 605 0.0137
639 TRANSFUSION 98 0.0137
640 DISORIENTATION 408 0.0137
641 RASH PUSTULAR 82 0.0137
642 ARRHYTHMIA 465 0.0137
643 SEIZURE 843 0.0136
644 COUGH 2281 0.0136
645 GROIN PAIN 84 0.0136
646 SKIN DISCOLOURATION 418 0.0135
647 GASTRITIS 247 0.0135
648 BODY TEMPERATURE DECREASED 87 0.0135
649 SKIN CANCER 122 0.0135
650 HYPOAESTHESIA 1372 0.0135
651 LYMPHOMA 128 0.0135
652 MOTOR DYSFUNCTION 91 0.0135
653 JAUNDICE 281 0.0135
654 EMPHYSEMA 99 0.0134
655 RETINAL DETACHMENT 81 0.0134
656 WHITE BLOOD CELL COUNT INCREASED 372 0.0134
657 UPPER GASTROINTESTINAL HAEMORRHAGE 168 0.0134
658 PARAESTHESIA 1446 0.0134
659 GLAUCOMA 172 0.0133
660 INFUSION SITE PAIN 79 0.0133
661 HEPATITIS 231 0.0133
662 RECTAL HAEMORRHAGE 408 0.0133
663 PHARYNGITIS 115 0.0132
664 MUSCLE SPASMS 1646 0.0132
665 TOOTH FRACTURE 98 0.0132
666 INTESTINAL OBSTRUCTION 297 0.0131
667 ASPIRATION 91 0.0130
668 APNOEA 77 0.0130
669 HYPERTENSION 1782 0.0130
670 HAEMODIALYSIS 101 0.0130
671 RHINORRHOEA 497 0.0130
672 CHEST DISCOMFORT 837 0.0130
673 CARDIAC FAILURE CONGESTIVE 884 0.0129
674 NIGHT SWEATS 257 0.0129
675 GLOMERULAR FILTRATION RATE DECREASED 81 0.0129
676 DEPRESSED LEVEL OF CONSCIOUSNESS 339 0.0128
677 LIVER DISORDER 362 0.0128
678 NERVOUS SYSTEM DISORDER 313 0.0127
679 NOCTURIA 94 0.0127
680 SKIN DISORDER 246 0.0127
681 GAIT INABILITY 168 0.0127
682 SINUSITIS 825 0.0127
683 FLUSHING 971 0.0127
684 PRESYNCOPE 201 0.0126
685 LIMB DISCOMFORT 239 0.0126
686 DEAFNESS 208 0.0126
687 FISTULA 83 0.0124
688 PROSTATIC SPECIFIC ANTIGEN INCREASED 111 0.0124
689 LIVER INJURY 131 0.0124
690 GRAND MAL CONVULSION 114 0.0123
691 JOINT SWELLING 853 0.0123
692 INFLAMMATION 342 0.0123
693 EXOSTOSIS 74 0.0123
694 GASTRIC HAEMORRHAGE 108 0.0122
695 FEEDING DISORDER 116 0.0122
696 EAR PAIN 152 0.0122
697 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 439 0.0121
698 NEPHROPATHY 75 0.0121
699 ELECTROCARDIOGRAM QT PROLONGED 277 0.0121
700 GASTROINTESTINAL HAEMORRHAGE 820 0.0121
701 FALL 2656 0.0121
702 BURSITIS 81 0.0121
703 GLOSSODYNIA 130 0.0120
704 EPILEPSY 222 0.0119
705 BALANCE DISORDER 710 0.0119
706 CHEST PAIN 1573 0.0119
707 PALLOR 204 0.0119
708 HYPOAESTHESIA ORAL 123 0.0119
709 TREMOR 1383 0.0118
710 TRANSIENT ISCHAEMIC ATTACK 300 0.0118
711 PANCREATITIS 444 0.0117
712 LUNG NEOPLASM MALIGNANT 230 0.0117
713 DRUG INTERACTION 1268 0.0116
714 MANIA 140 0.0116
715 HEART RATE DECREASED 249 0.0116
716 HYPOTONIA 86 0.0115
717 EATING DISORDER 162 0.0115
718 DYSPEPSIA 735 0.0115
719 DYSURIA 294 0.0115
720 ABDOMINAL DISTENSION 773 0.0115
721 INTENTIONAL PRODUCT USE ISSUE 436 0.0114
722 BLOOD PRESSURE ABNORMAL 127 0.0114
723 DERMATITIS 137 0.0114
724 DIABETES MELLITUS 621 0.0114
725 LACERATION 107 0.0113
726 COLON CANCER 103 0.0113
727 TUBULOINTERSTITIAL NEPHRITIS 133 0.0113
728 PARALYSIS 112 0.0113
729 ERYTHEMA 1544 0.0113
730 HAEMATEMESIS 206 0.0113
731 SUBARACHNOID HAEMORRHAGE 79 0.0112
732 THROAT TIGHTNESS 204 0.0112
733 UVEITIS 74 0.0112
734 BLOOD POTASSIUM INCREASED 126 0.0112
735 UPPER LIMB FRACTURE 155 0.0111
736 DIPLOPIA 191 0.0111
737 HYPERSENSITIVITY 1323 0.0111
738 OSTEOPOROSIS 283 0.0110
739 INTERNATIONAL NORMALISED RATIO INCREASED 279 0.0110
740 PSYCHOMOTOR HYPERACTIVITY 140 0.0110
741 HYPERSOMNIA 204 0.0109
742 APHONIA 92 0.0108
743 CHOLELITHIASIS 256 0.0108
744 GASTRIC ULCER 148 0.0108
745 SWELLING 599 0.0107
746 MUSCULOSKELETAL DISORDER 143 0.0107
747 DEMENTIA 168 0.0107
748 CARDIAC DISORDER 690 0.0107
749 GASTROENTERITIS VIRAL 121 0.0107
750 HEPATIC ENZYME INCREASED 426 0.0107
751 DRY EYE 241 0.0107
752 NASOPHARYNGITIS 1205 0.0106
753 BLISTER 361 0.0106
754 CENTRAL NERVOUS SYSTEM LESION 114 0.0106
755 RASH MACULAR 223 0.0105
756 LOWER LIMB FRACTURE 117 0.0105
757 HYPOACUSIS 243 0.0105
758 CYST 84 0.0104
759 ILLNESS 88 0.0104
760 RESPIRATORY TRACT CONGESTION 107 0.0104
761 ULCER 109 0.0104
762 FEELING HOT 422 0.0103
763 GALLBLADDER DISORDER 140 0.0103
764 ANGINA PECTORIS 222 0.0103
765 HAEMORRHAGE 694 0.0103
766 CONTUSION 638 0.0103
767 TOOTH LOSS 126 0.0102
768 HAEMATOMA 195 0.0102
769 THERAPEUTIC RESPONSE DECREASED 387 0.0102
770 THIRST 111 0.0102
771 FEELING JITTERY 146 0.0102
772 EAR INFECTION 155 0.0102
773 INSOMNIA 1888 0.0102
774 OROPHARYNGEAL PAIN 587 0.0101
775 POST PROCEDURAL HAEMORRHAGE 87 0.0101
776 MUSCLE TWITCHING 163 0.0100
777 OSTEOARTHRITIS 270 0.0100
778 HIATUS HERNIA 97 0.0100
779 COLD SWEAT 122 0.0099
780 FOETAL EXPOSURE DURING PREGNANCY 475 0.0099
781 RESTLESSNESS 253 0.0099
782 ARTHROPATHY 328 0.0099
783 EYE DISORDER 203 0.0099
784 HYPERHIDROSIS 888 0.0099
785 CONVULSION 559 0.0098
786 AGITATION 536 0.0098
787 TUBERCULOSIS 81 0.0097
788 WHEEZING 313 0.0097
789 MUSCULOSKELETAL PAIN 438 0.0097
790 HEART RATE INCREASED 626 0.0097
791 COMA 321 0.0097
792 FLATULENCE 358 0.0096
793 SPEECH DISORDER 353 0.0096
794 POOR QUALITY SLEEP 126 0.0096
795 LOSS OF CONSCIOUSNESS 867 0.0096
796 WEIGHT INCREASED 1373 0.0096
797 VISION BLURRED 860 0.0096
798 GASTROOESOPHAGEAL REFLUX DISEASE 501 0.0095
799 PSYCHOTIC DISORDER 200 0.0095
800 BLOOD PRESSURE SYSTOLIC INCREASED 104 0.0095
801 SKIN REACTION 89 0.0095
802 DRUG LEVEL INCREASED 99 0.0095
803 ROTATOR CUFF SYNDROME 86 0.0094
804 EOSINOPHILIA 102 0.0094
805 VISUAL ACUITY REDUCED 268 0.0094
806 BLINDNESS 237 0.0093
807 TINNITUS 291 0.0093
808 NECK PAIN 344 0.0093
809 SINUS CONGESTION 85 0.0093
810 BLOOD URINE PRESENT 125 0.0092
811 BLOOD PRESSURE INCREASED 905 0.0092
812 GASTRIC DISORDER 259 0.0092
813 JOINT INJURY 124 0.0092
814 DIZZINESS 3051 0.0092
815 ANOREXIA 118 0.0091
816 FRACTURE 128 0.0091
817 SEROTONIN SYNDROME 108 0.0091
818 POLLAKIURIA 253 0.0091
819 HYPOKINESIA 89 0.0091
820 SKIN EXFOLIATION 449 0.0090
821 NODULE 73 0.0089
822 NEOPLASM MALIGNANT 309 0.0089
823 END STAGE RENAL DISEASE 122 0.0088
824 SOMNOLENCE 1188 0.0088
825 BREAST CANCER 335 0.0088
826 HYPOTHYROIDISM 165 0.0087
827 DIALYSIS 92 0.0087
828 SKIN FISSURES 71 0.0087
829 MALAISE 2692 0.0087
830 PAIN IN EXTREMITY 1765 0.0087
831 PRODUCT DOSE OMISSION 599 0.0087
832 PRODUCT USE ISSUE 918 0.0087
833 LOCAL SWELLING 151 0.0086
834 PRURITUS 1802 0.0086
835 NEPHROLITHIASIS 238 0.0086
836 BEDRIDDEN 76 0.0086
837 LIMB INJURY 133 0.0085
838 HAEMATOCHEZIA 266 0.0085
839 RESPIRATORY ARREST 191 0.0084
840 ABDOMINAL PAIN UPPER 1117 0.0084
841 VERTIGO 359 0.0084
842 HEAD INJURY 174 0.0084
843 KIDNEY INFECTION 102 0.0083
844 PHOTOPHOBIA 95 0.0083
845 QUALITY OF LIFE DECREASED 75 0.0083
846 HEART RATE IRREGULAR 137 0.0083
847 PAIN 2974 0.0083
848 EYE SWELLING 200 0.0083
849 CONTRAINDICATED PRODUCT ADMINISTERED 113 0.0083
850 BLOOD GLUCOSE ABNORMAL 99 0.0082
851 HYPERTHYROIDISM 74 0.0082
852 HYPOGLYCAEMIA 288 0.0082
853 SLEEP DISORDER 329 0.0082
854 THERAPEUTIC PRODUCT EFFECT DECREASED 121 0.0081
855 MUSCULOSKELETAL DISCOMFORT 89 0.0081
856 DIABETIC KETOACIDOSIS 130 0.0081
857 BLOOD TRIGLYCERIDES INCREASED 108 0.0081
858 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 182 0.0080
859 GAIT DISTURBANCE 1047 0.0080
860 ANGIOEDEMA 234 0.0080
861 BLOOD CHOLESTEROL INCREASED 247 0.0080
862 CEREBROVASCULAR ACCIDENT 1001 0.0080
863 HEAD DISCOMFORT 81 0.0079
864 LACTIC ACIDOSIS 148 0.0079
865 EYELID OEDEMA 76 0.0078
866 PHOTOSENSITIVITY REACTION 87 0.0078
867 CARDIOVASCULAR DISORDER 168 0.0078
868 DRY SKIN 591 0.0078
869 SLEEP APNOEA SYNDROME 104 0.0078
870 VISUAL IMPAIRMENT 557 0.0077
871 BLOOD PRESSURE FLUCTUATION 114 0.0077
872 POST PROCEDURAL COMPLICATION 106 0.0077
873 MATERNAL EXPOSURE DURING PREGNANCY 315 0.0077
874 ANOSMIA 74 0.0076
875 SWOLLEN TONGUE 172 0.0076
876 EMOTIONAL DISTRESS 393 0.0076
877 RETCHING 107 0.0076
878 FAECES DISCOLOURED 116 0.0076
879 HALLUCINATION 356 0.0076
880 NASAL CONGESTION 256 0.0076
881 PANCREATIC CARCINOMA 88 0.0075
882 HOT FLUSH 333 0.0075
883 RESTLESS LEGS SYNDROME 94 0.0075
884 CONDITION AGGRAVATED 1181 0.0075
885 EXPOSURE DURING PREGNANCY 268 0.0075
886 FEMUR FRACTURE 177 0.0075
887 DRY MOUTH 398 0.0075
888 MEMORY IMPAIRMENT 673 0.0075
889 HERNIA 87 0.0074
890 CHRONIC KIDNEY DISEASE 409 0.0074
891 ANXIETY 1435 0.0074
892 DYSSTASIA 142 0.0073
893 URTICARIA 761 0.0073
894 MENTAL IMPAIRMENT 121 0.0072
895 OCULAR HYPERAEMIA 192 0.0072
896 ANHEDONIA 134 0.0072
897 MOOD ALTERED 136 0.0072
898 ARTHRITIS 353 0.0072
899 MYALGIA 840 0.0072
900 THROAT IRRITATION 200 0.0072
901 COORDINATION ABNORMAL 80 0.0071
902 ABDOMINAL DISCOMFORT 714 0.0071
903 PELVIC PAIN 94 0.0071
904 ADVERSE EVENT 445 0.0071
905 CORONARY ARTERY DISEASE 184 0.0071
906 AMNESIA 334 0.0070
907 ARTHRALGIA 1714 0.0070
908 BLOOD GLUCOSE INCREASED 958 0.0070
909 CHROMATURIA 114 0.0070
910 SENSORY DISTURBANCE 86 0.0070
911 ABASIA 173 0.0070
912 RHABDOMYOLYSIS 203 0.0070
913 TENDONITIS 78 0.0069
914 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 189 0.0068
915 MOBILITY DECREASED 299 0.0068
916 RASH PAPULAR 111 0.0067
917 DISCOMFORT 202 0.0067
918 HEADACHE 2783 0.0067
919 MUSCULOSKELETAL STIFFNESS 361 0.0066
920 FEELING COLD 124 0.0066
921 DIABETES MELLITUS INADEQUATE CONTROL 80 0.0066
922 SNEEZING 86 0.0065
923 FIBROMYALGIA 94 0.0065
924 PRODUCT DOSE OMISSION ISSUE 167 0.0065
925 PHARYNGEAL OEDEMA 96 0.0064
926 BLOOD CREATINE PHOSPHOKINASE INCREASED 145 0.0064
927 ABDOMINAL PAIN LOWER 114 0.0064
928 ILL-DEFINED DISORDER 158 0.0064
929 FEELING ABNORMAL 1059 0.0063
930 NERVOUSNESS 249 0.0062
931 IRRITABILITY 279 0.0062
932 DISTURBANCE IN ATTENTION 235 0.0062
933 DEPRESSED MOOD 206 0.0061
934 ECZEMA 95 0.0061
935 DYSKINESIA 172 0.0061
936 MYOCARDIAL INFARCTION 877 0.0061
937 DEPRESSION 1013 0.0061
938 PRURITUS GENERALISED 132 0.0061
939 BURNING SENSATION 292 0.0060
940 PALPITATIONS 472 0.0060
941 FOOT FRACTURE 76 0.0060
942 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 107 0.0058
943 TYPE 2 DIABETES MELLITUS 132 0.0056
944 EYE PRURITUS 91 0.0056
945 ASTHMA 322 0.0056
946 MENTAL DISORDER 152 0.0055
947 EYE PAIN 172 0.0055
948 LIP SWELLING 122 0.0054
949 MOVEMENT DISORDER 118 0.0053
950 DRUG EFFECT INCOMPLETE 195 0.0053
951 DRUG HYPERSENSITIVITY 727 0.0053
952 JOINT STIFFNESS 91 0.0053
953 MOOD SWINGS 125 0.0052
954 INFLUENZA LIKE ILLNESS 318 0.0051
955 INJURY 270 0.0050
956 ACTIVITIES OF DAILY LIVING IMPAIRED 98 0.0049
957 THERAPY CESSATION 150 0.0049
958 DRUG INEFFECTIVE 3957 0.0049
959 ABNORMAL BEHAVIOUR 157 0.0048
960 AGGRESSION 182 0.0048
961 DRUG DOSE OMISSION 757 0.0046
962 RENAL INJURY 112 0.0045
963 TREATMENT NONCOMPLIANCE 141 0.0045
964 ROAD TRAFFIC ACCIDENT 124 0.0043
965 ERECTILE DYSFUNCTION 72 0.0043
966 EMOTIONAL DISORDER 93 0.0041
967 MIGRAINE 229 0.0040
968 HOSPITALISATION 301 0.0038
969 ACCIDENTAL OVERDOSE 87 0.0037
970 MEDICATION ERROR 142 0.0036
971 STRESS 154 0.0035
972 BLOOD GLUCOSE DECREASED 123 0.0035
973 ANGER 87 0.0034
974 VAGINAL HAEMORRHAGE 112 0.0033
975 PANIC ATTACK 71 0.0028
976 ACNE 147 0.0027
977 DRUG EFFECT DECREASED 148 0.0027
978 DRUG EXPOSURE DURING PREGNANCY 92 0.0027
979 NO ADVERSE EVENT 212 0.0026
980 EYE IRRITATION 74 0.0025
981 INCORRECT DOSE ADMINISTERED 231 0.0022
982 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 109 0.0022
983 OVERDOSE 255 0.0021
984 DRUG DEPENDENCE 110 0.0021
985 INTENTIONAL PRODUCT MISUSE 103 0.0019
986 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 131 0.0018
987 SUICIDAL IDEATION 118 0.0018
988 RHEUMATOID ARTHRITIS 119 0.0018
989 UNDERDOSE 80 0.0017
990 SKIN BURNING SENSATION 82 0.0016
991 INJECTION SITE REACTION 76 0.0016
992 INJECTION SITE ERYTHEMA 126 0.0015
993 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 109 0.0011
994 PSORIASIS 86 0.0011
995 PRODUCT QUALITY ISSUE 91 0.0008
996 INJECTION SITE PAIN 135 0.0008